Community factors in the development of antibiotic resistance

Annual Review of Public Health

Volumn 28, Issue , 2007, Pages 435-447

  Larson, Elaine ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Drug development; Infection control; Personal hygiene; Prescriptions

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; ISONIAZID; METICILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE;

AGRICULTURE; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIAL STRAIN; CONFERENCE PAPER; DRUG USE; ENVIRONMENTAL FACTOR; FOOD AND DRUG ADMINISTRATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH BEHAVIOR; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; INFECTION CONTROL; NONHUMAN; PERSONAL HYGIENE; POLITICAL PARTICIPATION; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGROCHEMICALS; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG INDUSTRY; DRUG RESISTANCE, MICROBIAL; HEALTH POLICY; HEALTH SERVICES MISUSE; HUMANS; RISK FACTORS;

EID: 34249739583     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.publhealth.28.021406.144020     Document Type: Conference Paper

References (82)

1. Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS, Bager F. 2001. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob. Agents Chemother. 45:2054-59
2. Aiello AE, Cimiotti J, Della-Latta P, Larson EL. 2003. A comparison of the bacteria found on the hands of 'homemakers' and neonatal intensive care unit nurses. J. Hosp. Infect. 54:310-15
3. Aiello AE, Marshall B, Levy SB, Della-Latta P, Larson E. 2004. Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimitrob. Agents Chemother. 48:2973-79
4. Aiello AE, Marshall B, Levy SB, Della-Latta P, Lin SX, Larson E. 2005. Antibacterial cleaning products and drug resistance. Emerg. Infect. Dis. 11:1565-70
5. Alanis AJ. 2005. Resistance to antibiotics: Are we in the postantibiotic era? Arch. Med. Res. 36:697-705
6. Allen KD, Anson JJ, Parsons LA, Frost NG. 1997. Staff carriage of methicillin-resistant staphylococcus aureus (eMRSA 15) and the home environment: a case report. J. Hosp. Infect. 35:307-11
7. Anderson A, Nelson M, Baker N, Rossiter S, Angulo F. 2005. Public health consequences of use of antimicrobial agents in agriculture. In Food Safety Assurance and Veterinary Public Health. Risk Management Strategies: Monitoring and Surveillance, Vol. 3, ed. J Smulders, J Collins, pp. 173-85. The Neth.: Wageningen Acad.
8. Arason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S. 1996. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Bri. Med. J. 313:387-91
9. Arnold S, Straus S. 2005. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst. Rev. 4:CD003539
10. Avorn J, Barrett J, Davey P, McEwen S, O'Brien T, Levy S. 2001. Antibiotic resistance: synthesis of recommendations by expert policy groups. http://whqlibdoc.who.int/ hq/2001/WHO_CDS_CSR_DRS_2001.10.pdf
11. Ball AP, Bartlett JG, Craig WA, Drusano GL, Felmingham D, Garau JA, et al. 2004. Future trends in antimicrobial chemotherapy: expert opinion on the 43rd icaac. J. Chemother. 16:419-36
12. Baran J Jr, Ramanathan J, Riederer KM, Khatib R. 2002. Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households. Infect. Control Hosp. Epidemiol. 23:23-26
13. Boyce JM, Cookson B, Christiansen K, Hori S, Vuopio-Varkila J, Kocagoz S, et al. 2005. Meticillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 5:653-63
14. Campbell KM, Vaughn AF, Russell KL, Smith B, Jimenez DL, Barrozo CP, et al. 2004. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J. Clin. Microbiol. 42:4050-53
15. Canton R, Loza E, Morosini MI, Baquero F. 2002. Aitimicrobial resistance among isolates of Streptococcus pyogenes and Staphylococcus aureus in the Protekt Antimicrobial Surveillance program during 1999-2000. J. Antimicrob. Chemother. 50(Suppl. 1):9-24
16. Chambers HF. 2001. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7:178-82
17. Charlebois ED, Bangsberg DR, Moss NJ, Moore MR, Moss AR, Chambers HF, et al. 2002. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin. Infect. Dis. 34:425-33
18. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR, Schweizer HP. 2001. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxb mutants overexpressing mexcd-oprj. Antimicrob. Agents Chemother. 45:428-32
19. Cober MP, Johnson CE. 2005. Otitis media: review of the 2004 treatment guidelines. Ann. Pharmacother. 39:1879-87
20. Corbett KK, Gonzales R, Leeman-Castillo BA, Flores E, Maselli J, Kafadar K. 2005. Appropriate antibiotic use: variation in knowledge and awareness by hispanic ethnicity and language. Prev. Med. 40:162-69
21. Dailey L, Coombs GW, O'Brien FG, Pearman JW, Christiansen K, Grubb WB, et al. 2005. Methicillin-resistant Staphylococcus aureus, western Australia. Emerg. Infect. Dis. 11:1584-90
22. Faustini A, Hall AJ, Perucci CA. 2006. Risk factors for multi-drug resistant tuberculosis in Europe: a systematic review. Thorax 61:158-63
23. FDA. 2000. FDA task force on antimicrobial resistance: key recommendations and report. http://www.fda.gov/oc/antimicrobial/ taskforce2000.html
24. Felmingham D, Gruneberg RN. 2000. The alexander project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J. Antimicrob. Chemother. 45:191-203
25. File TM Jr. 2004. Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am. J. Med. 117(Suppl. 3A):39S-40
26. Foster KR, Grundmann H. 2006. Do we need to put society first? The potential for tragedy in antimicrobial resistance. PLOS Med. 3:e29
27. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. 1996. The role of under-staffing in central venous catheter-associated bloodstream infections. Infect. Contr. Hosp. Epidemiol. 17:150-58
28. Furuya EY, Lowy FD. 2006. Antimicrobial-resistant bacteria in the community setting. Nat. Rev. Microbiol. 4:36-45
29. Gonzalez BE, Martinez-Aguilar G, Hulten KG, Hammerman WA, Coss-Bu J, Avalos-Mishaan A, et al. 2005. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatr. 115:642-48
30. Graham P, Lin X, Larson E. 2006. A United States population-based survey of Staphylococcus aureus colonization. Ann. Intern. Med. 144:318-25
31. Greko C. 1999. Antibiotics as growth promoters. Acta. Vet. Scand. Suppl. 92:87-100
32. Harbarth S, Samore MH. 2005. Antimicrobial resistance determinants and future control. Emerg. Infect. Dis. 11:794-801
33. Hirakata Y, Yanagihara K, Miyazaki Y, Tomono K, Kobayashi I, Kohno S. 2005. Antimicrobial susceptibilities of potential bacterial pathogens in adults with acute respiratory tract infections prospective epidemiological network investigating community-acquired infection surveillance in Nagasaki (penicillin) study. Diagn. Microbiol. Infect. Dis. 51:271-80
34. IDSA. 2004. Bad bugs, no drugs as antibiotic discovery stagnates . . . a public health crisis brews. http://www.idsociety.org/pa/ IDSA_Paper4_final_web.pdf
35. Jacobs MR. 2004. Streptococcus pneumoniae: epidemiology and patterns of resistance. Am. J. Med. 117(Suppl. 3A):3S-15
36. Kassenborg HD, Smith KE, Vugia DJ, Rabatsky-Ehr T, Bates MR, et al. 2004. Fluoroquinolone-resistant campylobacter infections: Eating poultry outside of the home and foreign travel are risk factors. Clin. Infect. Dis. 38(Suppl. 3):S279-84
37. Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, et al. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352:468-75
38. Klugman KP, Lonks JR. 2005. Hidden epidemic of macrolide-resistant pneumococci. Emerg. Infect. Dis. 11:802-7
39. Knobler S, Lemon S, Najafi M, Burroughs T. 2003. The Resistance Phenomenon in Microbes and Infections Disease Vectors. Washington, DC: Natl. Acad. Press. 336 pp.
40. Ladd E. 2005. The use of antibiotics for viral upper respiratory tract infections: an analysis of nurse practitioner and physician prescribing practices in ambulatory care, 1997-2001. J. Am. Acad. Nurs. Pract. 17:416-24
41. Larson E, Grullon-Figueroa L. 2004. Availability of antibiotics without prescription in New York City. J. Urban Health 81:498-504
42. Larson E, Dilone J, Garcia M, Smolowitz J. 2006. Factors which influence Latino community members to self-prescribe antibiotics. Nurs. Res. 55:95-102
43. Larson E, Lin SX, Gomez-Duarte C. 2003. Antibiotic use in hispanic households, New York City. Emerg. Infect. Dis. 9:1096-102
44. Larson EL, Lin SX, Gomez-Pichardo C, Della-Latta P. 2004. Effect of antibacterial home cleaning and handwashing products on infectious disease symptoms: a randomized, double-blind trial. Ann. Intern. Med. 140:321-29
45. Leeb M. 2004. Antibiotics: a shot in the arm. Nature 431:892-93
46. Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ. 2003. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch. Dermatol. 139:467-71
47. Levy SB. 2002. The 2000 garrod lecture. Factors impacting on the problem of antibiotic resistance. J. Antimicrob. Chemother. 49:25-30
48. Levy SB, FitzGerald GB, Macone AB. 1976. Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man. Nature 260:40-42
49. Levy SB, Marshall B. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10:S122-29
50. Luby SP, Agboatwalla M, Painter J, Altaf A, Billhimer WL, Hoekstra RM. 2004. Effect of intensive handwashing promotion on childhood diarrhea in high-risk communities in Pakistan: a randomized controlled trial. J. Am. Med. Assoc. 291:2547-54
51. Maltezou HC, Giamarellou H. 2006. Community-acquired methicillin- resistant Staphylococcus aureus infections. Int. J. Antimicrob. B Agents 27:87-96
52. Martinez JL, Baquero F. 2002. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin. Microbiol. Rev. 15:647-79
53. Mathews WC, Caperna JC, Barber RE, Torriani FJ, Miller LG, May S, et al. 2005. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J. Acquir. Immune Defic. Syndr. 40:155-60
54. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, et al. 2005. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 40:1738-44
55. Melander E, Ekdahl K, Jonsson G, Molstad S. 2000. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr. Infect. Dis. J. 19:1172-77
56. Microbiol. Am. Soc. 2000. The clean hands campaign. http://www.washup.org/ page03.htm
57. MMWR. 2004. Trends in tuberculosis - United States, 1998-2003. MMWR 53:209-14
58. Molbak K. 2004. Spread of resistant bacteria and resistance genes from animals to humans - the public health consequences. J. Vet. Med. B Infect. Dis. Vet. Public Health 51:364-69
59. Nguyen DM, Mascola L, Brancoft E. 2005. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg. Infect. Dis. 11:526-32
60. Nicolau D. 2002. Clinical and economic implications of antimicrobial resistance for the management of community-acquired respiratory tract infections. J. Antimicrob. Chemother. 50(Suppl. 1):61-70
61. Norrby SR, Nord CE, Finch R. 2005. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect. Dis. 5:115-19
62. Okeke IN. 2005. Antibiotic use and resistance in developing countries. See Ref. 39, pp. 132-39
63. Okeke IN, Fayinka ST, Lamikanra A. 2000. Antibiotic resistance in escherichia coli from Nigerian students, 1986-1998. Emerg. Infect. Dis. 6:393-96
64. Oteo J, Lazaro E, de Abajo FJ, Baquero F, Campos J. 2004. Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates. J. Clin. Microbiol. 42:5571-77
65. Paolo WF Jr, Nosanchuk JD. 2004. Tuberculosis in New York City: recent lessons and a look ahead. Lancet Infect. Dis. 4:287-93
66. Parikh SL, Xiao G, Tonge PJ. 2000. Inhibition of inha, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid. Biochemistry 39:7645-50
67. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, et al. 2005. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 65:1256-58
68. San Martin B, Lapierre L, Toro C, Bravo V, Cornejo J, Hormazabal JC, et al. 2005. Isolation and molecular characterization of quinolone resistant Salmonella spp. from poultry farms. Vet. Microbiol. 110:239-44
69. Schrag SJ, McGee L, Whitney CG, Beall B, Craig AS, Choate ME, et al. 2004. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob. Agents Chemother. 48:3016-23
70. Shryock T. 2005. The use of antimicrobials in food-producing animals. See Ref. 39, pp. 147-58
71. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr. 2004. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38:1279-86
72. Sundberg P. 2002. Resistant bacteria in retail meats and antimicrobial use in animals. N. Engl. J. Med. 346:777-79
73. Trepka MJ, Belongia EA, Chyou PH, Davis JP, Schwartz B. 2001. The effect of a community intervention trial on parental knowledge and awareness of antibiotic resistance and appropriate antibiotic use in children. Pediatric 107:E6
74. van den Bogaard AE, Willems R, London N, Top J, Stobberingh EE. 2002. Antibiotic resistance of faecal enterococci in poultry, poultry farmers and poultry slaughterers. J. Antimicrob. Chemother. 49:497-505
75. van Duijkeren E, Wolfhagen MJ, Heck ME, Wannet WJ. 2005. Transmission of a panton-valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. J. Clin. Microbiol. 43:6209-11
76. Vargas J, Carballo M, Hernandez M, Rojas N, Jimenez O, Riera J, et al. 2005. Rapid development of auricular infection due to imipenem-resistant Pseudomonas aeruginosa following self-administered piercing of high ear. Clin. Infect. Dis. 41:1823-24
77. Weese J. 2005. Methicillin-resistant Staphylococcus aureus: an emerging pathogen in small animals. J. Am. Anim. Hosp. Assoc. 41:150-57
78. Weissman J, Besser RE. 2004. Promoting appropriate antibiotic use for pediatric patients: a social ecological framework. Semin. Pediatr. Infect. Dis. 15:41-51
79. Whitney CG, Klugman KP. 2004. Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine. Semin. Pediatr. Infect. Dis. 15:86-93
80. WHO. 1999. Containing Antimicrobial Resistance: Review of the Literature and Report of a WHO Workshop on the Development of a Global Strategy for the Containment of Antimicrobial Resistance (No. WHO/CDS/CSR/DRS/99.2). Geneva: WHO
81. Wright JG, Tengelsen LA, Smith KE, Bender JB, Frank RK, et al. 2005. Multidrug-resistant Salmonella typhimurium in four animal facilities. Emerg. Infect. Dis. 11:1235-41
82. Wright SW, Wrenn KD, Haynes ML. 1999. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J. Gen. Intern. Med. 14:606-9